Femara (letrozole) to prevent recurrent breast cancer

You'll see more women taking Femara (letrozole) to prevent recurrent breast cancer.

Tamoxifen is the standard of care for hormone-receptor-positive breast cancer. Taking it for 5 years reduces the risk of recurrence by 47% and improves survival.

But after 5 years tamoxifen's benefits wane.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote